Toremifene reduces hot flashes and vertebral fractures in men with prostate cancer on androgen-deprivation therapy for prostate cancer. Medscape Medical News
This article reviews the diagnostic criteria for AIH, the indications for and results of liver transplantation, as well as the management of recurrent AIH. disease.
The progression-free survival benefits from approved antiangiogenic drugs are modest and may not be accompanied by overall survival improvements. Why persist in this "vein"? Nature Reviews Clinical Oncology
Although new therapies for prostate cancer are always welcome, they further complicate the challenges that clinicians face in advising and managing patients, notes Dr. Gerald Chodak. Medscape Urology
Dr. Matthew Smith discusses updated clinical data on denosumab and toremifene in preventing bone loss in men with prostate cancer treated with androgen deprivation therapy. Medscape Hematology-Oncology
Robert Den, MD, a radiation oncologist from Jefferson University, received the Resident Digital Poster Discussion Award from the American Society for Radiation Oncology (ASTRO). Medscape Medical News